Nonclinical Efficacy Testing » Non-Clinical CROs and Agencies » Anapharm Bioanalytics (formerly: Anapharm Europe)

Anapharm Bioanalytics (formerly: Anapharm Europe)

Table of Contents
Table of Contents

This article introduces Anapharm Bioanalytics, a company that possesses a team with extensive experience and a lab equipped with cutting-edge technology. We investigate and summarize the characteristics and strengths of the non-clinical studies they handle, as well as past case examples.

Non-clinical studies commissioned by Anapharm Bioanalytics

Technical expertise and a wealth of analytical methods

Anapharm Bioanalytics is equipped with advanced instruments, including LC-MS/MS.Provides a wide range of biological sample analyses from low molecular weight to high molecular weight.With over 30 years of experience, the company offers one-stop solutions from preclinical studies to Phase 3 and bioequivalence trials. They also have strengths in complex analyses, such as high-sensitivity assays below the picogram level.Technical expertise with numerous verified methodsWe offer

Strict quality assurance that meets international standards

At Anapharm Bioanalytics, where we place a very high importance on quality,Conduct studies in compliance with GLP (Good Laboratory Practice) and GCP (Good Clinical Practice).The company's Quality Assurance Unit is led by a director with extensive industry experience, ensuring the quality of research data through strict adherence to guidelines, continuous monitoring, process improvement, and staff training.

Emphasize transparent communication with customers.

Anapharm Bioanalytics champions a "customer-first" philosophy.We value transparent and effective communication.is a feature. Each project is assigned a dedicated Study Director. We provide prompt support and regular progress reports, meeting customer requirements throughout each project.

An example of a pathological model held by Anapharm Bioanalytics

Analyze biological samples

Anapharm Bioanalytics isAnalytical CRO specializing in biological sample analysisTherefore, we do not sell or provide specific animal disease models. We support non-clinical development by directly analyzing biological samples such as blood received from clients in our own laboratories.

Anapharm Bioanalytics Non-Clinical Study Case Examples

Over 20 years of proven experience since its establishment

Anapharm Bioanalytics isA long track record is a distinguishing feature.This can be said. Although specific compound names are not disclosed due to sponsor confidentiality, they have a wealth of experience and a proven track record of successfully conducting non-clinical TK (toxicokinetics) studies for novel small and large molecule pharmaceuticals and developing and validating molecular methods for biomarker measurement for over 20 years since their establishment.

Anapharm Bioanalytics Company Information

Address Encuny 22, 2nd floor, 08038 Barcelona, Spain
Tel +34 93 223 86 36
Website https://www.anapharmbioanalytics.com/

3 Recommended Contract Research Organizations
for Non-Clinical Studies
— by Target goal and Expertise

In non-clinical development, the choice of contract research organization shapes the quality of the data and the time it takes to reach the next decision. Below, three CROs are introduced by the type of study they support: pharmacology (efficacy) studies, safety studies, and pharmacokinetic (PK/PD) studies. Each summary describes the services the company offers so that you can match a provider to your target and development objective.

Pharmacology (Efficacy) StudiesDisease-Relevant Models for
Translational Drug Evaluation
SMC Laboratories, Inc.
Reference: SMC Laboratories, Inc. official website (https://www.smccro-lab.com/)

SMC Laboratories, Inc.

SMC Laboratories is a specialized non-clinical CRO focused on in vivo pharmacology and efficacy studies using disease-relevant animal models, particularly in fibrosis, inflammation, metabolic diseases, and oncology.

Areas of Expertise
Disease-Relevant Model Portfolio

SMC Laboratories offers models covering the liver, lung, kidney, intestine, and oncology. Its portfolio includes the proprietary STAM™ model for MASH, fibrosis, and hepatocellular carcinoma.

Study Design Based on Target Biology

Study plans are developed around the target biology, mechanism of action, disease stage, and development objective. Pharmacological endpoints can be combined with histopathology, biomarkers, and disease-specific readouts.

Support from Target Validation to Proof of Concept

With experience from more than 1,000 studies for clients in 30 countries, SMC Laboratories supports programs from target validation and candidate selection through in vivo proof-of-concept studies.

Safety StudiesComprehensive Safety Assessment for
Preclinical Development
Charles River Laboratories
Reference: Charles River Laboratories official website (https://www.criver.com/)

Charles River Laboratories

Charles River provides non-clinical toxicology and safety assessment services for programs ranging from exploratory safety studies to IND-enabling development.

Areas of Expertise
General Toxicology Across Study Designs

Services include single- and repeat-dose toxicology, dose-range finding, and general toxicology studies across multiple species and administration routes.

Non-GLP and GLP Study Support

Charles River supports both non-GLP and GLP studies, allowing sponsors to progress from early safety characterization to studies intended for regulatory submissions.

Integrated IND-Enabling Safety Assessment

Toxicology studies can be integrated with toxicokinetics, clinical pathology, histopathology, and safety pharmacology to support interpretation and IND-enabling safety packages.

Pharmacokinetic (PK/PD) StudiesConnecting Drug Exposure with
Pharmacological Response
Inotiv
Reference: Inotiv official website (https://www.inotiv.com/)

Inotiv

Inotiv provides integrated PK/PD, DMPK, and bioanalytical services to characterize drug exposure and its relationship with pharmacological response.

Areas of Expertise
Pharmacokinetic Characterization

PK studies characterize exposure, half-life, clearance, and other pharmacokinetic parameters needed to understand how a candidate behaves in the selected model.

Exposure–Response Evaluation

Pharmacokinetic data can be combined with pharmacodynamic endpoints and bioanalysis to evaluate the relationship between drug exposure and pharmacological response.

Integrated DMPK and Development Support

Integrated DMPK, pharmacology, and safety information supports candidate comparison, dose selection, dosing-frequency optimization, and decisions about subsequent preclinical development.

By Therapeutic Area
Disease Animal Models
and Reviews
Proven Capability, Expertise and Track Record
Top 3 Non-Clinical CRO Services